Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution
These products are often referred to as compounded GLP-1 medications. SAHPRAs enforcement action On 23 May 2026, SAHPRA announced that it had intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing semaglutide, tirzepatide, or combination formulations
Liu, L., Chen, J., Wang, L., Chen, C
Moving these peptides out of that category signals a meaningful regulatory shift
I feel more confident than ever. John: I was skeptical at first, but GLP-1s exceeded my expectations
Our mobile service eliminates the hassle of clinic visits while maintaining the highest safety standards